Clinical Trial Update: Safety, Tolerability and Efficacy of Sofosbuvir, Velpatasvir, and Voxilaprevir in Subjects With Previous DAA Experience [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety, tolerability, and efficacy of sofosbuvir/velpatasvir/voxilaprevir in patients with prior DAA experience for chronic hepatitis C…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Sofosbuvir/Velpatasvir/Voxilaprevir (sofosbuvir/velpatasvir/voxilaprevir)

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Chronic Hepatitis C | Phase 2 | Status: COMPLETED | Results posted: 2019-03-27